CytoDyn (CYDY) Net Equity Issued and Repurchased (2009 - 2026)
CytoDyn's Net Equity Issued and Repurchased came in at $12.23 million for fiscal Q1 2027 (quarter ended Aug 31, 2026), compared with $21,000 a year earlier and up 982.6% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Aug 31, 2026, CytoDyn reported Net Equity Issued and Repurchased of $30.46 million, up 316.7% year-over-year; for FY2026 (ended May 31, 2026), it came in at $18.24 million.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -3.9% (FY2021 to FY2026).
- Going back by fiscal year, Net Equity Issued and Repurchased was $1.19 million in FY2025 (-87.4%), $9.44 million in FY2024 (-64.0%), $26.23 million in FY2023 (-38.5%) and $42.62 million in FY2022 (+91.4%).
- The five-year range for quarterly Net Equity Issued and Repurchased is $21,000 (fiscal Q1 2026) to $26.62 million (fiscal Q2 2022).
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in fiscal Q4 2022 (growth of 896.5%), and the weakest in fiscal Q4 2023 (a decline of 82.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | CytoDyn | 334.50 Mn | 285.65 Mn | - | 12.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 12.23 Mn |
| May 31, 2026 | 1.13 Mn |
| Feb 28, 2026 | 17.09 Mn |
| Aug 31, 2025 | 21,000.00 |
| May 31, 2025 | 1.17 Mn |
| May 31, 2024 | 3.44 Mn |
| Feb 29, 2024 | 2.68 Mn |
| Nov 30, 2023 | 441,000.00 |
| Aug 31, 2023 | 2.88 Mn |
| May 31, 2023 | 1.36 Mn |
| Feb 28, 2023 | 13.35 Mn |
| Aug 31, 2022 | 11.52 Mn |
| May 31, 2022 | 7.88 Mn |
| Feb 28, 2022 | 4.55 Mn |
| Nov 30, 2021 | 26.62 Mn |
| Aug 31, 2021 | 3.56 Mn |
| May 31, 2021 | 791,000.00 |
| Feb 28, 2021 | 5.22 Mn |
| Nov 30, 2020 | 2.76 Mn |
| Aug 31, 2020 | 13.50 Mn |
API Access
CytoDyn Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();